Literature DB >> 17437619

Glutathione-S-transferase T1 and M1 gene polymorphisms in Greek patients with multiple sclerosis: a pilot study.

C Stavropoulou1, D Korakaki, H Rigana, G Voutsinas, M Polyzoi, V N Georgakakos, K N Manola, C E Karageorgiou, C Sambani.   

Abstract

Oxidative stress has been implicated in the pathogenesis of multiple sclerosis (MS). Glutathione-S-transferases (GSTs) are detoxification enzymes, evolved to protect cells against reactive oxygen metabolites. Both GSTT1 and GSTM1 genes exhibit a homozygous deletion polymorphism (null genotype) leading to abolished enzyme activity. We studied the impact of the GSTT1 and GSTM1 polymorphisms on MS susceptibility in a case-control study of 47 Greek patients and 165 controls. Correlations between genotype, gender and disability status were also investigated. The incidence of both GSTT1 and GSTM1 genotypes did not differ significantly between controls and patients. A significantly increased frequency of GSTM1 null genotype was found amongst female patients (65.5%) as compared with males (33.3%, P =0.04). The results suggest that GSTT1 and GSTM1 have no major pathogenetic role on the MS occurrence, nor any strong modifying effect on the disability status. The higher incidence of GSTM1 null genotype observed in female patients, suggests a possible role of the GSTM1 detoxification pathway in a gender-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17437619     DOI: 10.1111/j.1468-1331.2006.01678.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  8 in total

1.  Lack of association between GSTT1 polymorphism and endogenous or benzo[a]pyrene-induced sister chromatid exchanges as analyzed in metaphase or G2-phase lymphocytes.

Authors:  V I Hatzi; G I Terzoudi; C Stavropoulou; S I Malik; V Makropoulos; G E Pantelias
Journal:  Mol Biol Rep       Date:  2010-11-25       Impact factor: 2.316

2.  Meta-analysis of associations between MTHFR and GST polymorphisms and susceptibility to multiple sclerosis.

Authors:  Young Ho Lee; Young Ho Seo; Jae-Hoon Kim; Sung Jae Choi; Jong Dae Ji; Gwan Gyu Song
Journal:  Neurol Sci       Date:  2015-07-07       Impact factor: 3.307

3.  The GSTP1 gene variant rs1695 is not associated with an increased risk of multiple sclerosis.

Authors:  José A G Agúndez; Elena García-Martín; Carmen Martínez; Julián Benito-León; Jorge Millán-Pascual; María Díaz-Sánchez; Patricia Calleja; Diana Pisa; Laura Turpín-Fenoll; Hortensia Alonso-Navarro; Lucía Ayuso-Peralta; Dolores Torrecillas; Esteban García-Albea; José Francisco Plaza-Nieto; Félix Javier Jiménez-Jiménez
Journal:  Cell Mol Immunol       Date:  2014-12-22       Impact factor: 11.530

Review 4.  Genetic and Molecular Biology of Multiple Sclerosis Among Iranian Patients: An Overview.

Authors:  Meysam Moghbeli
Journal:  Cell Mol Neurobiol       Date:  2019-09-03       Impact factor: 5.046

5.  Glutathione S-transferase M1 and T1 null genotype frequency distribution among four tribal populations of western India.

Authors:  Prem Chandra Suthar; Pulakes Purkait; Kiran Uttaravalli; B N Sarkar; Rakshit Ameta; Mithun Sikdar
Journal:  J Genet       Date:  2018-03       Impact factor: 1.166

6.  Correlation between heavy metal exposure and GSTM1 polymorphism in Iranian multiple sclerosis patients.

Authors:  Mehdi Aliomrani; Mohammad A Sahraian; Hamid Shirkhanloo; Mohammad Sharifzadeh; Mohammad R Khoshayand; Mohammad H Ghahremani
Journal:  Neurol Sci       Date:  2017-04-21       Impact factor: 3.307

7.  The association of glutathione S-transferase GSTT1 and GSTM1 gene polymorphism with pseudoexfoliative glaucoma in a Pakistani population.

Authors:  Muhammad Imran Khan; Shazia Micheal; Farah Akhtar; Waqar Ahmed; Bushra Ijaz; Asifa Ahmed; Raheel Qamar
Journal:  Mol Vis       Date:  2010-10-26       Impact factor: 2.367

Review 8.  Sex-specific Behavioral Features of Rodent Models of Autism Spectrum Disorder.

Authors:  Se Jin Jeon; Edson Luck Gonzales; Darine Froy N Mabunga; Schley T Valencia; Do Gyeong Kim; Yujeong Kim; Keremkleroo Jym L Adil; Dongpil Shin; Donghyun Park; Chan Young Shin
Journal:  Exp Neurobiol       Date:  2018-10-31       Impact factor: 3.261

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.